KPT-9274 Inhibits Cellular NAD and Synergizes with Doxorubicin to Treat Dogs with LymphomaKPT-9274 Inhibits Cellular NAD and Synergizes with Doxorubicin to Treat Dogs with Lymphoma Learn More